Insiders Cytokinetics, Incorporated

Stocks

CYTK

US23282W6057

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 10/06/2026 BST			5-day change	1st Jan Change
67.07 ^USD	-2.02%		-5.42%	+5.56%

06-09	Cytokinetics, Incorporated Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-08-2026 09:18 AM
06-02	Cytokinetics Insider Sold Shares Worth $1,111,200, According to a Recent SEC Filing	MT

Insiders

06-02	Cytokinetics Insider Sold Shares Worth $1,111,200, According to a Recent SEC Filing	MT
05-28	Cytokinetics Insider Sold Shares Worth $579,075, According to a Recent SEC Filing	MT
05-20	Cytokinetics Insider Sold Shares Worth $264,915, According to a Recent SEC Filing	MT
05-05	Cytokinetics Insider Sold Shares Worth $270,795, According to a Recent SEC Filing	MT
05-04	Cytokinetics Insider Sold Shares Worth $1,030,705, According to a Recent SEC Filing	MT
04-29	Cytokinetics Insider Sold Shares Worth $447,150, According to a Recent SEC Filing	MT
04-15	Cytokinetics Insider Sold Shares Worth $490,350, According to a Recent SEC Filing	MT
04-15	Cytokinetics Insider Sold Shares Worth $491,783, According to a Recent SEC Filing	MT
04-08	Cytokinetics Insider Sold Shares Worth $292,985, According to a Recent SEC Filing	MT
02-06	Cytokinetics Insider Sold Shares Worth $928,950, According to a Recent SEC Filing	MT
12-23	Cytokinetics Insider Sold Shares Worth $1,322,800, According to a Recent SEC Filing	MT
12-02	Cytokinetics Insider Sold Shares Worth $559,125, According to a Recent SEC Filing	MT
12-02	Cytokinetics Insider Sold Shares Worth $1,872,430, According to a Recent SEC Filing	MT
11-14	Cytokinetics, Incorporated Appoints Jeffrey J. Hessekiel as Executive Vice President, Chief Legal and Administrative Officer, Effective as of November 14, 2025	CI
27/10/25	Cytokinetics Insider Sold Shares Worth $256,725, According to a Recent SEC Filing	MT
06/10/25	Cytokinetics Insider Sold Shares Worth $405,420, According to a Recent SEC Filing	MT
01/10/25	Cytokinetics Insider Sold Shares Worth $275,250, According to a Recent SEC Filing	MT
30/09/25	Cytokinetics Insider Sold Shares Worth $368,761, According to a Recent SEC Filing	MT
02/09/25	Cytokinetics Insider Sold Shares Worth $337,800, According to a Recent SEC Filing	MT
20/08/25	Cytokinetics Appoints Jim Daly to Board of Directors and as A Member of Compliance Committee Effective August 19, 2025	CI
21/04/25	Cytokinetics Insider Sold Shares Worth $769,200, According to a Recent SEC Filing	MT
31/03/25	Imbria Pharmaceuticals, Inc. announces tranche update	CI
31/03/25	Cytokinetics Insider Sold Shares Worth $611,250, According to a Recent SEC Filing	MT
17/03/25	Cytokinetics Insider Sold Shares Worth $943,426, According to a Recent SEC Filing	MT
05/03/25	Cytokinetics Insider Sold Shares Worth $1,080,750, According to a Recent SEC Filing	MT